124 related articles for article (PubMed ID: 10574335)
21. Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound.
Hsieh CY; Wu CC; Chen TM; Chen CA; Chen CL; Wang JF; Chang CF; Hsieh FJ
Cancer; 1995 May; 75(10):2518-22. PubMed ID: 7736396
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of preoperative chemoradiation in locally advanced cervical carcinoma.
Shibata K; Kikkawa F; Suzuki Y; Terauchi M; Kajiyama H; Ino K; Mizutani S
Gynecol Obstet Invest; 2004; 57(2):93-9. PubMed ID: 14671418
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
Mallery S; DeCamp M; Bueno R; Mentzer SJ; Sugarbaker DJ; Swanson SJ; Van Dam J
Cancer; 1999 Sep; 86(5):764-9. PubMed ID: 10463973
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of Standardized Intratumoral Metabolic Heterogeneity in Locally Advanced Cervical Cancer Treated With Chemoradiation.
Yang F; Young L; Grigsby P
Int J Gynecol Cancer; 2016 May; 26(4):777-84. PubMed ID: 27101524
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral blood flow analysis in endometrial carcinoma: correlation with tumor characteristics and risk for recurrence.
Alcázar JL; Galán MJ; Jurado M; López-García G
Gynecol Oncol; 2002 Feb; 84(2):258-62. PubMed ID: 11812084
[TBL] [Abstract][Full Text] [Related]
26. Effects of external radiotherapy on uterine blood flow in patients with advanced cervical carcinoma assessed by color Doppler ultrasonography.
Pirhonen JP; Grenman SA; Bredbacka AB; Bahado-Singh RO; Salmi TA
Cancer; 1995 Jul; 76(1):67-71. PubMed ID: 8630878
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.
Isenberg G; Chak A; Canto MI; Levitan N; Clayman J; Pollack BJ; Sivak MV
Gastrointest Endosc; 1998 Aug; 48(2):158-63. PubMed ID: 9717781
[TBL] [Abstract][Full Text] [Related]
28. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
[TBL] [Abstract][Full Text] [Related]
29. Transvaginal color Doppler sonography in predicting the response to chemotherapy in advanced cervical cancer.
Greco P; Cormio G; Vimercati A; Loverro G; Selvaggi L
Ultrasound Obstet Gynecol; 1997 Jan; 9(1):49-52. PubMed ID: 9060131
[TBL] [Abstract][Full Text] [Related]
30. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
31. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
Ferrandina G; Distefano M; Ludovisi M; Morganti A; Smaniotto D; D'Agostino G; Fanfani F; Scambia G
Ann Surg Oncol; 2007 Mar; 14(3):1129-35. PubMed ID: 17206484
[TBL] [Abstract][Full Text] [Related]
32. [Color doppler ultrasonography of uterine vessels during radiotherapy of advanced cervix cancers].
Stummvoll W; Ruschitzka G; Hammer J
Gynakol Geburtshilfliche Rundsch; 1994; 34(2):102-5. PubMed ID: 7950434
[TBL] [Abstract][Full Text] [Related]
33. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral blood flow analysis in endometrial cancer: does it differ among individual tumor characteristics?
Hata K; Hata T; Kitao M
Gynecol Oncol; 1996 Jun; 61(3):341-4. PubMed ID: 8641612
[TBL] [Abstract][Full Text] [Related]
35. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
36. Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
Siesto G; Romano F; Accardi A; Bulletti C; Iedà NP; Vitobello D
Int J Gynecol Cancer; 2016 Mar; 26(3):521-7. PubMed ID: 26825842
[TBL] [Abstract][Full Text] [Related]
37. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
[TBL] [Abstract][Full Text] [Related]
38. Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
Bohle W; Kasper M; Zoller WG
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859390
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
Levine EA; Farmer MR; Clark P; Mishra G; Ho C; Geisinger KR; Melin SA; Lovato J; Oaks T; Blackstock AW
Ann Surg; 2006 Apr; 243(4):472-8. PubMed ID: 16552197
[TBL] [Abstract][Full Text] [Related]
40. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
